Manitoba Institute of Cell Biology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
PLoS One. 2012;7(7):e40302. doi: 10.1371/journal.pone.0040302. Epub 2012 Jul 5.
The Deleted in liver cancer one (Dlc1) tumor suppressor gene encodes a RhoGTPase activating protein (RhoGAP). The Dlc1 gene has multiple transcriptional isoforms and we have previously established a mouse strain containing a gene trap (gt) insertion, which specifically reduces the expression of the 6.1 kb isoform (isoform 2). This gene trapped allele when homozygous results in embryonic lethality and the heterozygous gene trapped mice do not show an increased incidence of cancers, suggesting that cooperating oncogenic changes may be required for transformation. In the present work, we have studied the in vivo cooperation between oncogenic K-Ras2 and Dlc1 genes in tumourigenesis. We have observed an increase in invasive thymic cancers, including both thymomas and lymphomas, resulting in significantly shortened life spans in mice heterozygous for the gt Dlc1 allele and an inducible LSL-K-Ras2(G12D) allele compared with the LSL-K-Ras2(G12D) only mice. The heterozygous mice showed a high degree of metastasis in the lung. We have found tumour specific selective hypermethylation of the Dlc1 isoform 2 promoter and reduction of the corresponding protein expression in thymic lymphoma (TL) and thymic epithelial carcinoma (TEC) derived from the thymic tumours. The Dlc1 deficient thymic lymphoma cell lines exhibited increased trans-endothelial cell migration. TEC cell lines also exhibited increased stress fiber formation and Rho activity. Introduction of the three Dlc1 isoforms tagged with GFP into these cells resulted in different morphological changes. These results suggest that loss of expression of only isoform 2 may be sufficient for the development of thymic tumors and metastasis.
肝癌缺失蛋白 1(Dlc1)肿瘤抑制基因编码一种 RhoGTPase 激活蛋白(RhoGAP)。Dlc1 基因有多个转录异构体,我们之前建立了一种含有基因陷阱(gt)插入的小鼠品系,该插入物特异性降低 6.1kb 异构体(异构体 2)的表达。纯合子缺失该基因会导致胚胎致死,杂合子缺失基因的小鼠不会增加癌症的发生率,这表明可能需要协同的致癌变化来实现转化。在本研究中,我们研究了致癌性 K-Ras2 和 Dlc1 基因在肿瘤发生中的体内协同作用。我们观察到侵袭性胸腺癌(包括胸腺瘤和淋巴瘤)的发生率增加,导致携带 gt Dlc1 等位基因和可诱导 LSL-K-Ras2(G12D)等位基因的杂合子小鼠的寿命显著缩短,与仅携带 LSL-K-Ras2(G12D)的小鼠相比。杂合子小鼠的肺部转移程度很高。我们发现,在胸腺瘤和胸腺癌衍生的胸腺淋巴瘤(TL)和胸腺癌(TEC)中,Dlc1 异构体 2 启动子的肿瘤特异性选择性超甲基化和相应蛋白表达减少。Dlc1 缺陷型胸腺淋巴瘤细胞系表现出增强的跨内皮细胞迁移。TEC 细胞系也表现出增加的应激纤维形成和 Rho 活性。将 GFP 标记的三种 Dlc1 异构体导入这些细胞后,细胞形态发生不同的变化。这些结果表明,仅缺失异构体 2 可能足以促进胸腺肿瘤和转移的发生。